Literature DB >> 29698323

Does simplification to dolutegravir-based dual regimens impact on the CD4+/CD8+ T-cell ratio?

Amedeo F Capetti1, GianCarlo Orofino2, Laura Paladini1, Gaetana Sterrantino3, Simona DiGiambenedetto4, Giuseppe V De Socio5, Giovanni Cenderello6, Maria V Cossu1, Giuliano Rizzardini1,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29698323     DOI： 10.1097/QAD.0000000000001784

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  1 in total

1.  Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV.

Authors:  Javier Martínez-Sanz; Raquel Ron; Elena Moreno; Matilde Sánchez-Conde; Alfonso Muriel; Luis Fernando López Cortés; José Ramón Blanco; Juan Antonio Pineda; Álvaro Mena; Sonia Calzado Isbert; Santiago Moreno; Sergio Serrano-Villar
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.